Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential

Eva W. Stratford(Oslo University Hospital), Ola Myklebost(Oslo University Hospital), A.B. Wennerström(Oslo University Hospital), Silje U. Lauvrak(Oslo University Hospital), Ruth Holm(University of Aleppo), Russell Castro(Oslo University Hospital), Else Munthe(Oslo University Hospital), Bodil Bjerkehagen(Oslo University Hospital)
Clinical Sarcoma Research
August 1, 2011
10.1186/2045-3329-1-8
Cited by 29

Related Papers

Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
|PubMed|1993|589
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
|PLoS ONE|2011|222
Monogenic and polygenic determinants of sarcoma risk: an international genetic study
|The Lancet Oncology|2016|213
Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients
|Cancer|1994|201
Prognostic significance of TP53 alterations in breast carcinoma
|British Journal of Cancer|1993|168